OBB Newsletter

  • Enter your e-mail address below to subscribe to the Orange Book Blog newsletter. If a new post is added during the day, you'll receive it by e-mail the next morning.

Enter your email address:

Delivered by FeedBurner

AddThis Feed Button

Disclaimer

  • Orange Book Blog is published for informational purposes only; it contains no legal advice whatsoever. Publication of Orange Book Blog does not create an attorney-client relationship. Orange Book Blog is Aaron Barkoff's personal website and it is intended primarily for other attorneys. Orange Book Blog is not edited by McDonnell Boehnen Hulbert & Berghoff LLP ("MBHB") or its clients. Therefore, no part of Orange Book Blog--whether information, commentary, or other--may be attributed to MBHB or its clients. Readers should be aware that MBHB represents many companies in the pharmaceutical and biotechnology industries, and therefore Orange Book Blog may occasionally report on news that relates to MBHB clients. Orange Book Blog will always strive to be unbiased in its reporting. All information on Orange Book Blog should be double-checked for its accuracy and current applicability. -- © Aaron F. Barkoff 2006-08

« Federal Circuit Addresses Effect of 271(e)(1) "Safe Harbor" in ITC Actions | Main | OBB News Briefs »

March 26, 2008

IQPC "Optimising Pharmaceutical Patent Lifecycles" Conference, London, April 29-30

Legal IQ, a division of IQPC, will be holding a highly interactive two-day conference, "Optimising Pharmaceutical Patent Lifecycles," in London, April 29-30.  The conference will focus on how to maximize product revenues and yet avoid anti-competitive issues through strategic patent lifecycle management.

Featuring seventeen international experts, the conference will cover hot topics such as how to maintain a competitive advantage by integrating legal and commercial strategies to extend product lifecycles, how to update patent strategies by assessing the implications of current U.S. and European case law, how to prevent competition law violations and how to maximize the commercial value of patents by strategically managing the interplay between generics and innovators.

The conference features two practical tutorials ("P.I.T. Stop" sessions), led by experts from Bristows and Simmons & Simmons, which will allow attendees to discuss and work through common industry problems guided by the experts' perspectives.  The main focus will be on building a commercially sound patent lifecycle management strategy and reassessing the impact that patent practices have on competition law positions in Europe and the U.S.

The conference is specifically designed to answer pressing questions from top figures at EPO, UK IPO, Indian PO and USPTO, provide practical lessons in how to apply the key patent lifecycle extension strategies, and ensure that attendees maximize the efficiency of potential collaborations between innovators and generics.

For more information or the register, please visit the conference website.

Comments

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.